Bridget Ogilvie | |
|---|---|
.jpg) Ogilvie in 1987 | |
| Born | Bridget Margaret Ogilvie (1938-03-24)24 March 1938 (age 87)[2] Glen Innes, New South Wales, Australia |
| Alma mater | University of Cambridge |
| Awards | FRS DBE PhD[1] |
| Scientific career | |
| Institutions | University of Cambridge National Institute for Medical Research Wellcome Trust Zeneca Group plc Imperial College London |
| Thesis | Nippostrongylus braziliensis: a study of the life cycle and immunological response of the host (1964) |
| Website | www |
Dame Bridget Margaret Ogilvie,ACDBE FRS[3] (born 24 March 1938)[2] is an Australian and British scientist.[2][4][5][6]
Ogilvie was born in 1938 atGlen Innes, New South Wales, Australia, to John Mylne and Margaret Beryl (née McRae) Ogilvie. During her primary school years, she had a single teacher, and three other students in her class.[7]
She was educated at theNew England Girls' School (Armidale, New South Wales), finishing in 1955. She completed a Bachelor of Rural Science with First Class Honours at theUniversity of New England, graduating with the university medal in 1960. She was awarded a Commonwealth Scholarship to attendGirton College, Cambridge, where she earned a PhD for her work onNippostrongylus brasiliensis.[2][1][8][9][10]
Ogilvie joined theParasitology department at theMedical Research Council'sNational Institute for Medical Research (NIMR) in 1963 and spent her academic career there studyingimmune responses tonematodes (intestinal worms) until 1981 when she was appointed to the staff of the Wellcome Trust, becoming its Director in 1991]. She remained as Director until she retired in 1998. The key event during her Directorship was the establishment of the Sanger Institute at Hinxton near Cambridge, now the Wellcome Genome Campus.
At the end of her time at the Wellcome Trust, in 1998, she persuaded the government to join forces with the Wellcome Trust in funding the Joint Infrastructure Fund to improve university facilities for research.
She served on the main Board of Lloyds Bank, then Lloyds TSB bank. 1995–2000, and on the main Board of Zeneca, then AstraZeneca 1997–2006. She has many honorary degrees from universities in several countries and was the High Steward of the University of Cambridge from 2001 to 2009.[2][11]
Ogilvie was the first Chairperson of theMedicines for Malaria Venture (MMV) Board. Since her retirement, she has played a significant role in public engagement with science and science in education. As a trustee of the Science Museum and chair of theAstraZeneca science teaching trust, she served as chair ofCOPUS andTechniquest. She has served as the Vice Chair of the Board of Trustees ofSense about Science since its establishment and is a visiting professor atUniversity College London.[2][11]
In 1994, Ogilvie won the Kilgerran Prize of theFoundation for Science and Technology. In the 1996 New Year Honours List, Ogilvie was made a Dame Commander of theOrder of the British Empire (DBE) and was elected aFellow of the Royal Society (FRS) in 2003.[3]
In 2007, she was appointed a Companion of theOrder of Australia (AC), Australia's highest civilian honour, with the citation: "For service to science in the field of biomedical research, particularly related to veterinary and medical parasitology, and through support for research funding to improve global health."[12]
She is a member of the Advisory Council for theCampaign for Science and Engineering.[11] In 2008 she was elected to theAustralian Academy of Science. She is an Honorary Fellow ofSt Edmund's College, Cambridge.[13]She is an honorary member of theBritish Society for Immunology.[14]In 2016 the Wellcome Sanger Institute named their new sequencing operations building after her.[15]
“All text published under the heading 'Biography' on Fellow profile pages is available underCreative Commons Attribution 4.0 International License.” --"Royal Society Terms, conditions and policies". Archived from the original on 25 September 2015. Retrieved9 March 2016.
{{cite web}}: CS1 maint: bot: original URL status unknown (link)
| Preceded by | Director ofWellcome Trust 1991–1998 | Succeeded by |
{{cite journal}}:Cite journal requires|journal= (help)Authority control databases: Academics |
|---|
